Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $8.2 million.

  • Coeptis Therapeutics Holdings' Non-Current Assets rose 789.68% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.3 million, marking a year-over-year increase of 10871.06%. This contributed to the annual value of $7.9 million for FY2024, which is 17849.42% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Non-Current Assets of $8.2 million as of Q3 2025, which was up 789.68% from $8.5 million recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Non-Current Assets peaked at $75.8 million during Q1 2022, and registered a low of $2.5 million during Q1 2024.
  • For the 5-year period, Coeptis Therapeutics Holdings' Non-Current Assets averaged around $24.1 million, with its median value being $8.0 million (2024).
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Non-Current Assets plummeted by 9516.1% in 2023 and then soared by 25004.77% in 2025.
  • Coeptis Therapeutics Holdings' Non-Current Assets (Quarter) stood at $4.6 million in 2021, then decreased by 13.35% to $4.0 million in 2022, then decreased by 29.0% to $2.8 million in 2023, then soared by 178.49% to $7.9 million in 2024, then rose by 4.24% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $8.5 million for Q2 2025, and $8.8 million during Q1 2025.